{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:21:48Z","timestamp":1793906508211,"version":"4.8.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-024-03149-9","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T15:16:44Z","timestamp":1730301404000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bronchiectasis in a patient with Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Margherita S.","family":"Silani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Simonetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gramegna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Aliberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"3149_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.coi.2016.07.003","volume":"43","author":"\u00d8 Bruserud","year":"2016","unstructured":"Bruserud \u00d8, Oftedal BE, Wolff AB, Husebye ES. AIRE-mutations and autoimmune disease. Curr Opin Immunol. 2016;43:8\u201315. https:\/\/doi.org\/10.1016\/j.coi.2016.07.003.","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"3149_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri.2016.9","volume":"16","author":"MS Anderson","year":"2016","unstructured":"Anderson MS, Su MA. AIRE expands: new roles in immune tolerance and beyond. Nat Rev Immunol. 2016;16(4):247\u201358. https:\/\/doi.org\/10.1038\/nri.2016.9.","journal-title":"Nat Rev Immunol"},{"issue":"26","key":"3149_CR3","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1056\/NEJM199006283222601","volume":"322","author":"P Ahonen","year":"1990","unstructured":"Ahonen P, Myll\u00e4rniemi S, Sipil\u00e4 I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med. 1990;322(26):1829\u201336. https:\/\/doi.org\/10.1056\/NEJM199006283222601.","journal-title":"N Engl J Med"},{"key":"3149_CR4","doi-asserted-by":"publisher","unstructured":"Ferre EMN, Rose SR, Rosenzweig SD, Burbelo PD, Romito KR, Niemela JE, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016;1(13). https:\/\/doi.org\/10.1172\/jci.insight.88782.","DOI":"10.1172\/jci.insight.88782"},{"issue":"1","key":"3149_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/imr.12714","volume":"287","author":"GM Constantine","year":"2019","unstructured":"Constantine GM, Lionakis MS. Lessons from primary immunodeficiencies: autoimmune regulator and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Immunol Rev. 2019;287(1):103\u201320. https:\/\/doi.org\/10.1111\/imr.12714.","journal-title":"Immunol Rev"},{"issue":"495","key":"3149_CR6","doi-asserted-by":"publisher","first-page":"eaav5597","DOI":"10.1126\/scitranslmed.aav5597","volume":"11","author":"EMN Ferr\u00e9","year":"2019","unstructured":"Ferr\u00e9 EMN, Break TJ, Burbelo PD, Allg\u00e4uer M, Kleiner DE, Jin D, et al. Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance. Sci Transl Med. 2019;11(495):eaav5597. https:\/\/doi.org\/10.1126\/scitranslmed.aav5597.","journal-title":"Sci Transl Med"},{"issue":"11","key":"3149_CR7","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00431-008-0668-3","volume":"167","author":"F De Luca","year":"2008","unstructured":"De Luca F, Valenzise M, Alaggio R, Arrigo T, Crisafulli G, Salzano G, et al. Sicilian family with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and lethal lung disease in one of the affected brothers. Eur J Pediatr. 2008;167(11):1283\u20138. https:\/\/doi.org\/10.1007\/s00431-008-0668-3.","journal-title":"Eur J Pediatr"},{"issue":"101476","key":"3149_CR8","doi-asserted-by":"publisher","first-page":"101476","DOI":"10.1016\/j.rmcr.2021.101476","volume":"33","author":"SA Kubala","year":"2021","unstructured":"Kubala SA, Do HM, Ferr\u00e9 EMN, Schrump DS, Olivier KN, Walls JG, et al. Fatal autoimmune pneumonitis requiring bilobectomy and omental flap repair in a patient with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Respir Med Case Rep. 2021;33(101476):101476. https:\/\/doi.org\/10.1016\/j.rmcr.2021.101476.","journal-title":"Respir Med Case Rep"},{"issue":"11","key":"3149_CR9","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1073\/pnas.0809986106","volume":"106","author":"M Alimohammadi","year":"2009","unstructured":"Alimohammadi M, Dubois N, Sk\u00f6ldberg F, Hallgren A, Tardivel I, Hedstrand H, et al. Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen. Proc Natl Acad Sci U S A. 2009;106(11):4396\u2013401. https:\/\/doi.org\/10.1073\/pnas.0809986106.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3149_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/ppul.21520","volume":"47","author":"J Popler","year":"2012","unstructured":"Popler J, Alimohammadi M, K\u00e4mpe O, Dalin F, Dishop MK, Barker JM, et al. Autoimmune polyendocrine syndrome type 1: utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab. Pediatr Pulmonol. 2012;47(1):84\u20137. https:\/\/doi.org\/10.1002\/ppul.21520.","journal-title":"Pediatr Pulmonol"},{"key":"3149_CR11","doi-asserted-by":"publisher","unstructured":"Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50(3). https:\/\/doi.org\/10.1183\/13993003.00629-2017.","DOI":"10.1183\/13993003.00629-2017"},{"issue":"3","key":"3149_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S2213-2600(21)00277-0","volume":"10","author":"S Aliberti","year":"2022","unstructured":"Aliberti S, Goeminne PC, O\u2019Donnell AE, Aksamit TR, Al-Jahdali H, Barker AF, et al. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations. Lancet Respir Med. 2022;10(3):298\u2013306. https:\/\/doi.org\/10.1016\/S2213-2600(21)00277-0.","journal-title":"Lancet Respir Med"},{"key":"3149_CR13","first-page":"6","volume":"147","author":"PJ Cole","year":"1986","unstructured":"Cole PJ. Inflammation: a two-edged sword\u2013the model of bronchiectasis. Eur J Respir Dis Suppl. 1986;147:6\u201315.","journal-title":"Eur J Respir Dis Suppl"},{"issue":"1","key":"3149_CR14","doi-asserted-by":"publisher","first-page":"00388","DOI":"10.1183\/23120541.00388-2021","volume":"8","author":"S Aliberti","year":"2022","unstructured":"Aliberti S, Amati F, Gramegna A, Vigone B, Oriano M, Sotgiu G, et al. Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients. ERJ Open Res. 2022;8(1):00388\u20132021. https:\/\/doi.org\/10.1183\/23120541.00388-2021.","journal-title":"ERJ Open Res"},{"issue":"4","key":"3149_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1055\/s-0041-1730892","volume":"42","author":"F Amati","year":"2021","unstructured":"Amati F, Simonetta E, Pilocane T, Gramegna A, Goeminne P, Oriano M, et al. Diagnosis and initial investigation of bronchiectasis. Semin Respir Crit Care Med. 2021;42(4):513\u201324. https:\/\/doi.org\/10.1055\/s-0041-1730892.","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"3149_CR16","doi-asserted-by":"publisher","first-page":"1801269","DOI":"10.1183\/13993003.01269-2018","volume":"52","author":"R Boaventura","year":"2018","unstructured":"Boaventura R, Sibila O, Agusti A, Chalmers JD. Treatable traits in bronchiectasis. Eur Respir J. 2018;52(3):1801269. https:\/\/doi.org\/10.1183\/13993003.01269-2018.","journal-title":"Eur Respir J"},{"issue":"5","key":"3149_CR17","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","volume":"189","author":"JD Chalmers","year":"2014","unstructured":"Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189(5):576\u201385. https:\/\/doi.org\/10.1164\/rccm.201309-1575OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"3149_CR18","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1210\/jc.2011-2461","volume":"97","author":"A Meloni","year":"2012","unstructured":"Meloni A, Willcox N, Meager A, Atzeni M, Wolff ASB, Husebye ES, et al. Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in sardinian patients. J Clin Endocrinol Metab. 2012;97(4):1114\u201324. https:\/\/doi.org\/10.1210\/jc.2011-2461.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"3149_CR19","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.rmed.2013.04.013","volume":"107","author":"GA Anwar","year":"2013","unstructured":"Anwar GA, McDonnell MJ, Worthy SA, Bourke SC, Afolabi G, Lordan J, et al. Phenotyping adults with non-cystic fibrosis bronchiectasis: a prospective observational cohort study. Respir Med. 2013;107(7):1001\u20137. https:\/\/doi.org\/10.1016\/j.rmed.2013.04.013.","journal-title":"Respir Med"},{"issue":"4","key":"3149_CR20","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1177\/1479972317702139","volume":"14","author":"RM Gir\u00f3n","year":"2017","unstructured":"Gir\u00f3n RM, de Gracia Rold\u00e1n J, Olveira C, Vendrell M, Mart\u00ednez-Garc\u00eda M\u00c1, de la Rosa D, et al. Sex bias in diagnostic delay in bronchiectasis: an analysis of the Spanish historical Registry of Bronchiectasis. Chron Respir Dis. 2017;14(4):360\u20139. https:\/\/doi.org\/10.1177\/1479972317702139.","journal-title":"Chron Respir Dis"},{"key":"3149_CR21","doi-asserted-by":"crossref","unstructured":"Chessari C, Simonetta E, Amati F, Nigro M, Stainer A, Sotgiu G et al. Diagnostic delay in bronchiectasis: an Italian perspective. ERJ Open Res. 10(2):00713\u20132023. https:\/\/pubmed.ncbi.nlm.nih.gov\/38500794\/.","DOI":"10.1183\/23120541.00713-2023"},{"key":"3149_CR22","doi-asserted-by":"publisher","unstructured":"Ferr\u00e9 EMN, Schmitt MM, Lionakis MS. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Front Pediatr. 2021;9. https:\/\/doi.org\/10.3389\/fped.2021.723532.","DOI":"10.3389\/fped.2021.723532"},{"issue":"22","key":"3149_CR23","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","volume":"383","author":"JD Chalmers","year":"2020","unstructured":"Chalmers JD, Haworth CS, Metersky ML, Loebinger MR, Blasi F, Sibila O, et al. Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis. N Engl J Med. 2020;383(22):2127\u201337. https:\/\/doi.org\/10.1056\/NEJMoa2021713.","journal-title":"N Engl J Med"},{"issue":"3","key":"3149_CR24","doi-asserted-by":"publisher","first-page":"00695","DOI":"10.1183\/23120541.00695-2022","volume":"9","author":"JD Chalmers","year":"2023","unstructured":"Chalmers JD, Metersky ML, Feliciano J, Fernandez C, Teper A, Maes A, et al. Benefit-risk assessment of brensocatib for treatment of non-cystic fibrosis bronchiectasis. ERJ Open Res. 2023;9(3):00695\u20132022. https:\/\/doi.org\/10.1183\/23120541.00695-2022.","journal-title":"ERJ Open Res"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03149-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-024-03149-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03149-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T15:16:53Z","timestamp":1730301413000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-024-03149-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3149"],"URL":"https:\/\/doi.org\/10.1186\/s12890-024-03149-9","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"23 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval is not applicable. Consent to participate was obtained from the participant in writing.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. The editor in chief for this journal has a copy of this written consent and the ability to review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MSS, ES and ADA have no conflicts of interest or competing interest to report; AG reports personal fees from Chiesi, Foodar, Insmed, Neupharma, Vertex; FB reports grants and personal fees from AstraZeneca, Insmed, personal fees from Chiesi, GlaxoSmithKline, Grifols, Guidotti, Menarini, Novartis, Om Pharma, Pfizer, Sanofi, Vertex, Viatris, Zambon;SA reports grants and personal fees from Insmed, Chiesi, Fisher & Paykel, grants from GSK, personal fees from AstraZeneca, Brahms, CSL Behring, GlaxoSmithKline, Grifols, Menarini, Moderna, MSD Italia, Physioassist SAS, Thermofisher Scientific, Zambon.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"543"}}